10.1007/s00259-017-3728-y - Guideline for PET/CT imaging of neuro...

This document has been corrected

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

10.1007/s00259-017-3728-y

Published Online: 2017-05-25

Journal: European Journal of Nuclear Medicine and Molecular Imaging•Publisher: Springer Science and Business Media LLC

Authors: Andreas Kjaer•Arturo Chiti•Clemens Decristoforo•Domenico Rubello•Francesco Giammarile•Irene Virgolini•Jolanta Kunikowska•Mohsen Beheshti•Murat Fani Bozkurt•Roberto Delgado-Bolton•Sona Balogova•Stefano Fanti•Valentina Ambrosini•Wim J. G. Oyen

This document has been corrected

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

10.1007/s00259-017-3728-y

Published Online: 2017-05-25

Journal: European Journal of Nuclear Medicine and Molecular Imaging

NOW

2017-08-30•Erratum

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

10.1007/s00259-017-3807-0

* information provided by CrossRef

2017-08-30•Erratum

10.1007/s00259-017-3807-0

* information provided by CrossRef

2017-05-25•Published

2017-08-30•Erratum

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

10.1007/s00259-017-3807-0

* information provided by CrossRef

This document has been corrected

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

10.1007/s00259-017-3728-y

Published Online: 2017-05-25

Journal: European Journal of Nuclear Medicine and Molecular Imaging•Publisher: Springer Science and Business Media LLC